JPS55130999A - 111methylene steroid*its manufacture and pharmaceutic medicine containing same and having corpus luteum hormone activity - Google Patents

111methylene steroid*its manufacture and pharmaceutic medicine containing same and having corpus luteum hormone activity

Info

Publication number
JPS55130999A
JPS55130999A JP4056180A JP4056180A JPS55130999A JP S55130999 A JPS55130999 A JP S55130999A JP 4056180 A JP4056180 A JP 4056180A JP 4056180 A JP4056180 A JP 4056180A JP S55130999 A JPS55130999 A JP S55130999A
Authority
JP
Japan
Prior art keywords
pharmaceutic
steroid
manufacture
containing same
medicine containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4056180A
Other languages
English (en)
Japanese (ja)
Other versions
JPS629600B2 (en:Method
Inventor
Hofumaisutaa Herumuuto
Buiihieruto Ruudorufu
Anen Kurausu
Roorento Henrii
Shiyutainbetsuku Heruman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS55130999A publication Critical patent/JPS55130999A/ja
Publication of JPS629600B2 publication Critical patent/JPS629600B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP4056180A 1979-03-30 1980-03-31 111methylene steroid*its manufacture and pharmaceutic medicine containing same and having corpus luteum hormone activity Granted JPS55130999A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792913381 DE2913381A1 (de) 1979-03-30 1979-03-30 11-methylensteroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Publications (2)

Publication Number Publication Date
JPS55130999A true JPS55130999A (en) 1980-10-11
JPS629600B2 JPS629600B2 (en:Method) 1987-02-28

Family

ID=6067313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4056180A Granted JPS55130999A (en) 1979-03-30 1980-03-31 111methylene steroid*its manufacture and pharmaceutic medicine containing same and having corpus luteum hormone activity

Country Status (10)

Country Link
US (1) US4277468A (en:Method)
EP (1) EP0017094B1 (en:Method)
JP (1) JPS55130999A (en:Method)
AT (1) ATE429T1 (en:Method)
AU (1) AU529541B2 (en:Method)
CA (1) CA1146533A (en:Method)
DE (2) DE2913381A1 (en:Method)
DK (1) DK115780A (en:Method)
ES (1) ES489682A1 (en:Method)
IE (1) IE49572B1 (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57108100A (en) * 1980-11-07 1982-07-05 Schering Ag 11-methylene-delta15-steroid, manufacture and steroid medicine containing same

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4557867A (en) * 1984-01-25 1985-12-10 The Upjohn Company 11β-Difluoromethyl and (E)- and (Z)-11-fluoromethylene steriods
US4567000A (en) * 1984-08-31 1986-01-28 The Upjohn Company 11-Difluoromethylene steroids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE651797A (en:Method) * 1962-10-17
DE1934272A1 (de) * 1969-07-02 1971-01-14 Schering Ag d-18-Methyl-17 alpha-alkinyl-4-oestren-17 beta-ole
US3927046A (en) * 1972-12-09 1975-12-16 Akzona Inc Novel 11,11-alkylidene steroids

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57108100A (en) * 1980-11-07 1982-07-05 Schering Ag 11-methylene-delta15-steroid, manufacture and steroid medicine containing same

Also Published As

Publication number Publication date
ATE429T1 (de) 1981-12-15
EP0017094B1 (de) 1981-11-25
AU5698580A (en) 1980-10-02
DE3060093D1 (en) 1982-01-28
EP0017094A1 (de) 1980-10-15
ES489682A1 (es) 1980-09-16
DE2913381A1 (de) 1980-10-16
JPS629600B2 (en:Method) 1987-02-28
IE800640L (en) 1980-09-30
AU529541B2 (en) 1983-06-09
CA1146533A (en) 1983-05-17
IE49572B1 (en) 1985-10-30
DK115780A (da) 1980-10-01
US4277468A (en) 1981-07-07

Similar Documents

Publication Publication Date Title
IL61332A0 (en) 17 -substituted steroids, pharmaceutical preparations containing them and process for their manufacture
HK94190A (en) Substituted androsta-1,4-diene-3,17-diones and process for their preparation
ES300811A1 (es) Un procedimiento para la prepación de compuestos esteroides
JPS5536472A (en) Hemiester compound of sterylglycoside
HUT34513A (en) Process for production of 1-alkil-androsta-1,4-dien-3,17-dions and medical preparates consisting of such compounds
RO86647A (ro) Procedeu pentru prepararea unor derivati de 4''-epieritromicina
JPS55130999A (en) 111methylene steroid*its manufacture and pharmaceutic medicine containing same and having corpus luteum hormone activity
JPS57108100A (en) 11-methylene-delta15-steroid, manufacture and steroid medicine containing same
JPS55154996A (en) 16 alphaaalkylsteroid* its manufacture and medical blend containing it and having progesterone activity
DE3169460D1 (en) 6-alpha-methyl hydrocortisone derivatives, their preparation and their utilization
DE3060488D1 (en) 7-alkyl steroid derivatives, process for their preparation, their use in medicaments and pharmaceutical compositions containing them
EP0128839A3 (en) Labelled steroids, process for their preparation and intermediates, their use in the localization of the glucocorticoid receptors and in the dosage of the number of binding sites
HUT64365A (en) Process for steroid aromatase inhibitors containing 2-beta, 19-methylene-amino bridge and pharmaceutical preparatives containing them
GB983125A (en) Preparation of 9(11)-dehydro spirostanes and 3-esters thereof
ES473646A1 (es) Un procedimiento para la preparacion de nuevos esteroides dela serie del pregnano
DE3160492D1 (en) 1-hydroxy steroids, process for their preparation and pharmaceutical compositions containing these compounds
GB1030885A (en) 6-hydroxymethyl-and 6-acyloxymethyl-3-oxo-4, 6-dienic steroids
GB1145393A (en) Improvements in or relating to 17-‡-(alka-1',3'-diynyl)-steroids
GB876009A (en) Improvements in or relating to steroids and the manufacture thereof
GB949719A (en) Steroid-3-enolacylates and the preparation thereof
GB959869A (en) Oxasteroids of the pregnane series
GB1071207A (en) Improvements in or relating to 6,6-ethylene corticoids
GB893147A (en) Improvements in or relating to steroids and the manufacture thereof
AU5956280A (en) Digoxin derivatives
AU273017B2 (en) DERIVATIVES OF 10, 11-DIHYDRO-5 [H] DIBENZO adl-CYCLOPHTENE, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH DERIVATIVES